top of page
VOG | MPU3 | Sept 2026
Paula | MPU2 | Oct 2026
BIOFACH 2027
Ingredients
LanzaTech expands into producing nutritional protein from CO2
LanzaTech expands into producing nutritional protein from CO2

US biotech company LanzaTech has announced plans to expand into the alternative protein market, producing a microbial protein from CO2.

Cell-based
Start-up spotlight: Terviva
Start-up spotlight: Terviva

The Plant Base speaks to Terviva, an agriculture start-up developing nutritious food ingredients from the beans of pongamia trees.

Exclusives
Ingood by Olga presents fermented lentil-based egg alternative
Ingood by Olga presents fermented lentil-based egg alternative

Ingood by Olga, a French plant-based ingredients specialist, has developed an egg replacement solution made from fermented lentil powder.

New products
Döhler invests in Nukoko to scale ‘world's first’ cocoa-free chocolate
Döhler invests in Nukoko to scale ‘world's first’ cocoa-free chocolate

Döhler has announced a strategic partnership with Nukoko, a British start-up behind the ‘world’s first’ cocoa-free ‘bean-to-bar’ chocolate.

Partnerships
GNT to showcase possibilities with plant-based EXBERRY® colours
GNT to showcase possibilities with plant-based EXBERRY® colours

GNT will highlight the benefits of plant-based EXBERRY® colours for meat, seafood and dairy alternatives at Plant Based World Expo Europe.

Partner content
Baby steps: The rise of plant-based infant nutrition
Baby steps: The rise of plant-based infant nutrition

Melissa Bradshaw, editor of The Plant Base, explores the offerings available in the plant-based infant and toddler nutrition category.

Exclusives
GoodMills Innovation presents new plant-based ingredient solutions
GoodMills Innovation presents new plant-based ingredient solutions

GoodMills Innovation has announced it will showcase several new plant-based ingredient solutions at the FiE event in Germany next month.

New products
Helaina raises $45m to speed-up commercialisation of human bioactive proteins
Helaina raises $45m to speed-up commercialisation of human bioactive proteins

US biotech start-up Helaina has raised $45 million in a Series B funding round led by investment firm Avidity Partners.

Cell-based
Every secures foundational patent for precision-fermented ovalbumin
Every secures foundational patent for precision-fermented ovalbumin

US animal-free egg firm The Every Company has been granted a foundational patent for its precision-fermented ovalbumin.

Business
  • Page 42
bottom of page